0001127602-23-008815.txt : 20230303
0001127602-23-008815.hdr.sgml : 20230303
20230303172523
ACCESSION NUMBER: 0001127602-23-008815
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shetty Reshma P.
CENTRAL INDEX KEY: 0001873523
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40097
FILM NUMBER: 23705934
MAIL ADDRESS:
STREET 1: C/O SOARING EAGLE ACQUISITION CORP.
STREET 2: 955 FIFTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10075
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ginkgo Bioworks Holdings, Inc.
CENTRAL INDEX KEY: 0001830214
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 872652913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27 DRYDOCK AVENUE
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (877) 442-5362
MAIL ADDRESS:
STREET 1: 27 DRYDOCK AVENUE
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Soaring Eagle Acquisition Corp.
DATE OF NAME CHANGE: 20210210
FORMER COMPANY:
FORMER CONFORMED NAME: Spinning Eagle Acquisition Corp.
DATE OF NAME CHANGE: 20201027
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2023-03-01
0001830214
Ginkgo Bioworks Holdings, Inc.
DNA
0001873523
Shetty Reshma P.
C/O GINKGO BIOWORKS HOLDINGS
27 DRYDOCK AVENUE
BOSTON
MA
02210
1
1
1
See remarks
Class A Common Stock
2023-03-01
4
S
0
37650
1.394
D
13955854
D
Class A Common Stock
13993494
I
By Spouse
The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.33 to $1.475, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
President, COO & Founder
/s/ Karen Tepichin, Attorney-in-Fact
2023-03-03